Align Technology, Inc. ALGN
146.78
1.15
0.79%
as of 25 Sep
- Market cap
- $10.4B
- P/E
- 25.5×
Follow ALGN
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
Align Technology, Inc. (ALGN) Return on equity
Align Technology, Inc.'s return on equity over the twelve months to 30 June 2026 was 10.2%, down 0.2 percentage points from fiscal 2025 (10.4%). Over the past ten years it has ranged from 10.0% (fiscal 2022) to 77.6% (fiscal 2020); the current reading is higher than 18% of that period. That is above the Medical Instruments & Supplies industry median of 0.00% and above the Healthcare sector median of −32.0%.
Return on equity, annual
Annual
| Period | Return on equity | Change (points) |
|---|---|---|
| FY2025 | 10.4% | (0.87) |
| FY2024 | 11.3% | (1.05) |
| FY2023 | 12.3% | 2.30 |
| FY2022 | 10.0% | (12.51) |
| FY2021 | 22.5% | (55.03) |
| FY2020 | 77.6% | 43.48 |
| FY2019 | 34.1% | 0.82 |
| FY2018 | 33.3% | 11.72 |
| FY2017 | 21.5% | 0.95 |
| FY2016 | 20.6% | 2.59 |
Against its own ten years
Low 10.0%
High 77.6%
Ten-year median
20.6%
Current reading's percentile
18
Return on equity against peers
| Company | Return on equity |
|---|---|
| SOLV Solventum Corporation compare | 34.0% |
| ATR AptarGroup, Inc. compare | 13.5% |
| ALGN Align Technology, Inc. | 10.2% |
| STVN Stevanato Group S.p.A. compare | 9.21% |
| COO The Cooper Companies, Inc. compare | 6.84% |
| RGEN Repligen Corporation compare | 1.99% |
| BLCO Bausch + Lomb Corporation compare | −2.64% |
| AVTR Avantor, Inc. compare | −9.70% |
| BAX Baxter International Inc. compare | −15.8% |
| Medical Instruments & Supplies industry median | 0.00% |
| Healthcare sector median | −32.0% |
| Market median | 1.76% |
What Return on equity is
ROE shows how much profit a company earns for its shareholders on the equity they have in the business.
Annual: Net Income Allotted to Shareholders ÷ Average Common Equity; TTM: Net Income Allotted to Shareholders ÷ Average Common Equity (latest quarter)
More on ALGN
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement